Patient-Derived Xenograft Models of Lung Cancer

Lung cancer is the most common type of cancer worldwide, accounting for 13% of the total number of new diagnoses and is classified according to histological type by the size and appearance of cells: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Given the prominence of lung cancer diagnosed in the population, predictive preclinical models are essential for treatment development. Our lung cancer models are known to be the most predictive and provide the most accurate approach to evaluating an agents efficacy prior to entering the clinic. Crown Bioscience offers a large collection of over 300 well characterized models including 70 SCLC models, as well as primary and metastatic models. More